Scenario name,Rate of gonorrhea cases,"% cases successfully treated with CIP, TET, or CRO",% cases successfully treated with CIP,% cases successfully treated with TET,% cases successfully treated with CRO,"Effective lifespan of CIP, TET, and CRO",Effective lifespan of CIP,Effective lifespan of TET,Effective lifespan of CRO,delta - Rate of gonorrhea cases,"delta - Effective lifespan of CIP, TET, and CRO",delta - Effective lifespan of CIP,delta - Effective lifespan of TET,delta - Effective lifespan of CRO
Status quo (no rapid test),"11,896 (8,573, 15,302)","77.3% (69.9%, 84.2%)","0.0% (0.0%, 0.0%)","0.0% (0.0%, 0.0%)","77.3% (69.9%, 84.2%)","19.3 (17.5, 21.1)","0.0 (0.0, 0.0)","0.0 (0.0, 0.0)","19.3 (17.5, 21.1)",,,,,
"(p=(0.980, 0.750), q=(0.980, 0.975), c=0.500)","8,855 (6,509, 11,332)","88.0% (80.8%, 95.6%)","26.4% (19.1%, 31.9%)","2.7% (2.1%, 3.7%)","58.9% (49.4%, 67.3%)","22.0 (20.2, 23.9)","6.6 (4.8, 8.0)","0.7 (0.5, 0.9)","14.7 (12.4, 16.8)","-25.2% (-36.5%, -15.7%)","14.0% (8.9%, 23.0%)","nan% (nan%, nan%)","nan% (nan%, nan%)","-23.8% (-31.1%, -15.6%)"
"(p=(0.980, 0.750), q=(0.980, 0.975), c=0.750)","8,942 (6,512, 12,600)","88.5% (79.0%, 96.6%)","39.3% (27.3%, 48.5%)","4.0% (2.9%, 5.4%)","45.1% (34.0%, 57.0%)","22.1 (19.8, 24.2)","9.8 (6.8, 12.1)","1.0 (0.7, 1.3)","11.3 (8.5, 14.2)","-24.5% (-37.5%, -9.3%)","14.6% (7.1%, 24.6%)","nan% (nan%, nan%)","nan% (nan%, nan%)","-41.7% (-53.9%, -31.0%)"
"(p=(0.980, 0.750), q=(0.980, 0.975), c=1.000)","9,118 (6,735, 11,549)","88.4% (81.0%, 97.5%)","51.7% (37.0%, 63.8%)","5.2% (3.8%, 7.0%)","31.5% (16.7%, 45.8%)","22.1 (20.3, 24.4)","12.9 (9.2, 16.0)","1.3 (1.0, 1.7)","7.9 (4.2, 11.5)","-22.8% (-36.1%, -10.0%)","14.5% (8.2%, 24.7%)","nan% (nan%, nan%)","nan% (nan%, nan%)","-59.4% (-77.5%, -40.9%)"
